Biodesix, Inc. (BDSX)
28.08
+2.68
(+10.58%)
USD |
NASDAQ |
Aug 25, 16:00
29.00
+0.92
(+3.29%)
Pre-Market: 09:13
Biodesix Gross Profit Margin (Quarterly) : 82.06% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 82.06% |
| March 31, 2026 | 83.55% |
| December 31, 2025 | 83.03% |
| September 30, 2025 | 81.14% |
| June 30, 2025 | 79.86% |
| March 31, 2025 | 79.38% |
| December 31, 2024 | 78.75% |
| September 30, 2024 | 76.98% |
| June 30, 2024 | 78.37% |
| March 31, 2024 | 78.57% |
| December 31, 2023 | 77.00% |
| September 30, 2023 | 76.07% |
| June 30, 2023 | 72.73% |
| March 31, 2023 | 65.01% |
| Date | Value |
|---|---|
| December 31, 2022 | 65.59% |
| September 30, 2022 | 67.29% |
| June 30, 2022 | 63.65% |
| March 31, 2022 | 50.60% |
| December 31, 2021 | 65.49% |
| September 30, 2021 | 58.32% |
| June 30, 2021 | 40.39% |
| March 31, 2021 | 36.89% |
| December 31, 2020 | 45.79% |
| September 30, 2020 | 57.67% |
| June 30, 2020 | 55.79% |
| March 31, 2020 | 68.98% |
| December 31, 2019 | 77.87% |
| September 30, 2019 | 61.87% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| BillionToOne, Inc. | 70.45% |
| Quest Diagnostics, Inc. | 32.53% |
| Labcorp Holdings, Inc. | 27.71% |
| OPKO Health, Inc. | 37.32% |
| Psychemedics Corp. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -911.6% |
| Return on Assets | -30.43% |
| Return on Invested Capital | -36.86% |
| Profit Margin (Quarterly) | -27.08% |
| Operating Margin (Quarterly) | -20.01% |
| Return on Net Operating Assets | -46.05% |